The most frequently reported side effects across licensed weight loss medicines include: Nausea and vomiting particularly with GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda) Diarrhoea or constipation both can occur, sometimes alternating Oily or fatty stools, faecal urgency, and flatulence characteristic of orlistat (Xenical on prescription
Scenario 2: supply and cost constraints The medication landscape for GLP-1 agonists is volatile
Dietary supplementation with Lactium and L-theanine alleviates sleep disturbance in adults: a double-blind, randomized, placebo-controlled clinical study
For pharmaceutical GLP-1 support, compounded semaglutide and affordable tirzepatide options are available through licensed providers
General guidelines for Ozempic coverage by Aetna may include: Ozempic is on the patients Aetna health plan formulary
To view a copy of this license, visit About this article Cite this article Ribeiro-Parenti, L., Jarry, AC., Cavin, JB